Washington : The drug, Ranibizumab, has the potential to prevent blindness and visual impairment from age-related macular degeneration in non-Hispanic Caucasian patients, according to a computer-modeling study carried out by scientists at the Wilmer Eye Institute. Neil M. Bressler, M.D., of Wilmer Eye Institute, The Johns Hopkins University, Baltimore, and colleagues designed a modeling study using outcomes from three previous phase 3 ranibizumab trials. After gathering and analyzing data from the Beaver Dam Eye Study, as well as the US Census Bureau (2008), they predicted that 151,340 non-Hispanic Caucasian Americans would develop neovascular AMD in 2008.
Pune blast: ATS tracking online chats of IM terrorists
Devotees throng Mathura on the occassion of Guru Purnima
Shirdi Sai Baba is not God or Guru, says Shankaracharya
UPSC aspirants protest outside Rajnath Singh`s residence